Big Gain For Pyxis Oncology Inc.
Thu, Mar 30, 2023 at 07:08 PM
Pyxis Oncology Inc. (PYXS:NASDAQ) jumped higher at $6, representing a gain of 32.2%. On Thu, Mar 30, 2023, PYXS:NASDAQ touched a New 2-Week High of $6. The stock got featured on our News Catalysts scanner on Wed, Mar 22, 2023 at 06:53 AM in the 'INVESTOR UPDATE' category. From Thu, Mar 16, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days
About Pyxis Oncology Inc. (PYXS:NASDAQ)
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients.
Top 10 Gainers:
- SCYNEXIS, Inc. (SCYX:NASDAQ), 76.05%
- Palisade Bio Inc. (PALI:NASDAQ), 57.74%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 41.49%
- Boxed Inc. (BOXD:NYSE), 39.39%
- Digital Media Solutions Inc. Class A (DMS:NYSE), 33.42%
- Pyxis Oncology Inc. (PYXS:NASDAQ), 32.16%
- Prenetics Global Limited (PRE:NASDAQ), 31.26%
- SG Blocks, Inc. (SGBX:NASDAQ), 29.95%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 27.12%
- Professional Diversity Network, Inc. (IPDN:NASDAQ), 25.72%